![]() |
市场调查报告书
商品编码
1830968
CT扫描仪市场CT Scanner Market |
CT 扫描仪市场预计将从 2024 年的 70.1 亿美元扩大到 2031 年的 101 亿美元,2025 年至 2031 年的复合年增长率预计为 5.35%。
分析师的观点
CT扫描仪市场分析发现,关键的成长因素包括慢性病发病率上升、早期诊断需求日益增长以及医疗基础设施的进步。此外,CT扫描仪技术的创新预计将在2022年至2030年期间创造新的市场趋势。
电脑断层扫描 (CT) 扫描仪是一种医学影像设备,它利用不同角度的 X 光产生人体骨骼、血管和软组织的详细影像,比标准 X 光提供更详细的资讯。 CT 扫描仪通常用于评估因车祸或其他创伤而遭受内伤的患者。这种影像技术几乎可以显示所有身体部位,有助于诊断损伤或疾病。此外,在疾病诊断过程中,它也用于规划患处的医疗、手术或放射治疗。
市场概况慢性病发病率上升推动 CT 扫描仪市场发展根据美国国家生物医学影像和生物工程研究所 2022 年 6 月发布的报告,CT 已成为识别腹部潜在癌症或病变的可靠筛检工具。当怀疑有各种心臟疾病或异常时,可能会建议进行心臟 CT 扫描。头部 CT 扫描还可以帮助检测可能导致中风、出血和其他疾病的损伤、肿瘤和血栓。它们可以评估肺部是否有癌症、肺栓塞(血栓)、过多的液体以及其他疾病,例如肺气肿或肺炎。 CT 扫描由于其比传统 X 光更清晰的细节,特别适用于识别复杂的骨折、严重受损的关节或骨癌。因此,心血管疾病、癌症、神经系统疾病和骨科问题等慢性疾病的日益流行,导致全球大量患者接受电脑断层扫描。美国国家卫生统计中心报告称,2021年美国新增癌症病例1,898,160例,凸显了对电脑断层扫描仪日益增长的需求。此外,哈佛健康杂誌2021年9月的报告显示,美国每年约进行9,000万次CT扫描。
领先的公司正在推出先进的技术产品,以提升竞争优势。例如,2021年4月,日立公司推出了全新设计的Scenaria 64层CT扫描仪,旨在减少辐射暴露,提高效率,并为介入医生的诊疗工作提供支援。此次产品的发布是日立在竞争激烈的市场中强化产品供应的策略的一部分。
策略洞察新兴趋势CT扫描仪技术创新引领未来趋势随着人们对辐射暴露的担忧日益加深,CT扫描仪的剂量降低技术也备受关注。这包括迭代重建技术、自动曝光控制和其他剂量优化方法的改进,旨在降低辐射剂量的同时保持影像品质。美国癌症协会建议50岁及以上吸烟或有吸烟史的成年人每年进行一次低剂量CT (LDCT) 扫描筛检,以发现肺癌。
Science Direct 于 2022 年发表的一项研究考察了国家肺部筛检试验 (NLST) 中与呼吸系统疾病相关的偶然发现与呼吸系统疾病死亡率 (RDM) 之间的关係,其中不包括 LDCT 筛检中发现的肺癌。该研究纳入了 NLST LDCT 组的 26,722 名参与者,其中 25,002 名参与者接受了基线和后续 LDCT 筛检。研究发现,肺气肿和网状阴影等偶然发现与较高的 RDM 有关。
主要参与者实施的各种策略正在推动市场成长。例如,2023年12月,富士印度公司与Soorya Diagnostics LLP合作,将其最新的CT扫描设备引入Soorya Diagnostics中心,以推广筛检文化,并增强该地区获得优质医疗服务的机会。
报告细分和范围「CT扫描器市场」根据类型、架构、技术、应用、最终用户和地理进行分类。根据类型,市场分为固定式和便携式CT扫描器。根据架构,CT扫描器市场分为C型臂CT扫描器和O型臂CT扫描器。根据技术,市场细分为高切片CT、中型CT、低切片CT和锥形束CT。基于应用的细分包括肿瘤科、神经科、骨科和其他应用。对于最终用户,市场分为医院、诊断中心、研究实验室和兽医诊所。从地理上看,CT 扫描仪市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、义大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳洲、中国、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙乌地阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
基于类型的洞察CT扫描仪市场分为固定式和便携式CT扫描仪。固定式CT扫描仪在2022年占据了较大的市场份额,预计在2022年至2030年期间将呈现最高的复合年增长率。
基于架构的洞察 CT 扫描仪市场按架构分为 C 臂 CT 扫描仪和 O 臂 CT 扫描仪,其中 C 臂 CT 扫描仪领域在 2022 年引领市场。
基于技术的洞察 CT 扫描仪市场按技术细分为高切片 CT、中型 CT、低切片 CT 和锥形束 CT,其中高切片 CT 细分市场在 2022 年占据最大市场份额。
基于应用的洞察 CT 扫描仪市场按应用细分为肿瘤学、神经病学、骨科和其他应用,其中神经病学应用领域在 2022 年占据最大的市场份额。
基于终端用户的洞察:CT扫描仪市场按终端用户分为医院、诊断中心、研究实验室和兽医诊所。医院市场在2022年占据最大市场份额,预计在2022年至2030年期间将实现最高的复合年增长率。
CT扫描仪市场报告范围区域分析
预计北美将在2022年至2030年期间实现全球CT扫描仪市场的最高复合年增长率。北美在2022年占据了最大的市场份额,预计在整个预测期内都将保持领先地位。北美市场分为美国、加拿大和墨西哥,其中美国占据最大份额,这得益于该地区炎症性疾病的发病率上升、主要行业参与者的存在、医疗保健领域的进步、创新CT扫描系统的引入以及CT扫描技术的进步。
全球 CT 扫描仪市场的主要参与者包括 GE 医疗集团、西门子医疗私人有限公司、荷兰皇家飞利浦公司、东芝 IT 和控制系统公司、HTSI 医疗解决方案、岛津製作所、SAMSUNGHEALTHCARE.COM、东软集团、美敦力和深圳安科高科技股份有限公司。这些领先公司专注于扩大和多样化其市场影响力和客户群,预计这将对 CT 扫描仪市场产生积极影响。
主要市场参与者的一些显着进展包括:
2022 年 11 月,富士软片在美国推出了高阶 CT 扫描仪 SCENARIA View Focus Edition,该扫描仪采用先进的心臟运动校正技术 Cardio StillShot,可提供比传统影像重建方法高 6 倍的时间解析度。该设备适用于常规和高级临床应用,并在 2022 年 RSNA 上推出。 2022 年 4 月,Wipro GE 医疗推出了其先进的 Revolution Aspire CT 扫描仪,该扫描仪完全在印度的 Wipro GE 医疗设备製造工厂设计和製造,提供增强的成像智能,以实现更准确的临床诊断。 2021 年 11 月,西门子医疗推出了 Naeotom Alpha,这是第一款在美国和欧洲获准用于临床的光子计数 CT 扫描仪,与传统 CT 探测器相比,它提供了显着的改进,包括增强的分辨率和在超高分辨率扫描中将辐射剂量降低高达 45%。
The CT Scanner market is projected to expand from US$ 7.01 billion in 2024 to US$ 10.10 billion by 2031, with an estimated CAGR of 5.35% from 2025 to 2031.
Analyst's Perspective
The analysis of the CT Scanner market identifies key growth factors, including the rising incidence of chronic diseases, an increasing need for early diagnosis, and advancements in healthcare infrastructure. Additionally, innovations in CT scanner technology are expected to create new market trends from 2022 to 2030.
A computerized tomography (CT) scanner is a medical imaging device that utilizes X-rays from various angles to produce detailed images of the body's bones, blood vessels, and soft tissues, offering more detail than standard X-rays. CT scanners are commonly employed to assess individuals who may have sustained internal injuries from car accidents or other traumas. This imaging technique can visualize nearly all body parts, aiding in the diagnosis of injuries or diseases. Furthermore, it is utilized in planning medical, surgical, or radiation treatments for affected areas during disease diagnosis.
Market Overview
Rising Incidence of Chronic Diseases to Drive CT Scanner Market
According to a report by the National Institute of Biomedical Imaging and Bioengineering published in June 2022, CT has become a reliable screening tool for identifying potential cancers or lesions in the abdomen. A heart CT scan may be advised when various cardiac conditions or abnormalities are suspected. CT scans of the head can also help detect injuries, tumors, clots that may lead to strokes, bleeding, and other conditions. They can assess the lungs for cancers, pulmonary embolisms (blood clots), excess fluid, and other diseases such as emphysema or pneumonia. CT scans are particularly useful for identifying complex bone fractures, severely damaged joints, or bone cancers due to their superior detail compared to traditional X-rays. Consequently, the increasing prevalence of chronic conditions like cardiovascular diseases, cancer, neurological disorders, and orthopedic issues has led to a significant patient population undergoing computed tomography scans globally. The National Center for Health Statistics reported 1,898,160 new cancer cases in the US in 2021, highlighting the growing demand for computed tomography scanners. Additionally, a report from Harvard Health in September 2021 indicated that approximately 90.0 million CT scan procedures are conducted annually in the US.
Leading companies are launching advanced technological products to gain a competitive advantage. For example, in April 2021, Hitachi, Ltd. introduced the newly designed Scenaria 64-slice CT scanner, aimed at reducing radiation exposure, enhancing efficiency, and supporting interventionists in their practices. This product launch is part of Hitachi's strategy to strengthen its product offerings in a competitive market.
Strategic Insights
Emerging Trends
Technological Innovations in CT Scanners as a Future Trend
With growing concerns regarding radiation exposure, there has been a significant emphasis on dose-reduction technologies in CT scanners. This includes advancements in iterative reconstruction techniques, automatic exposure control, and other dose optimization methods to lower radiation doses while preserving image quality. The American Cancer Society recommends annual screening with a low-dose CT (LDCT) scan for adults aged 50 and older who smoke or have a history of smoking to detect lung cancer.
A study published by Science Direct in 2022 examined the relationship between incidental findings related to respiratory diseases from the National Lung Screening Trial (NLST) and respiratory disease mortality (RDM), excluding lung cancer detected during LDCT screenings. The study involved 26,722 participants in the NLST LDCT arm, with 25,002 undergoing both baseline and follow-up LDCT screenings. It found that incidental findings such as emphysema and reticular opacities were associated with higher RDM.
Various strategies implemented by key players are propelling market growth. For instance, in December 2023, Fujifilm India partnered with Soorya Diagnostics LLP to place its latest CT scan equipment at Soorya Diagnostics Center, promoting a culture of screening and enhancing access to quality healthcare services in the region.
Report Segmentation and Scope
The "CT scanner market" is categorized based on type, architecture, technology, application, end user, and geography. The market is divided into stationary and portable CT scanners based on type. In terms of architecture, the CT scanner market is split into C-arm CT Scanners and O-arm CT Scanners. By technology, the market is segmented into high slice CT, midsize CT, low slice CT, and cone beam CT. The application-based segmentation includes oncology, neurology, orthopedics, and other applications. For end users, the market is classified into hospitals, diagnostic centers, research laboratories, and veterinary clinics. Geographically, the CT scanner market is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Russia, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Type-Based InsightsThe CT scanner market is divided into stationary and portable CT scanners. The stationary CT scanners segment held a larger market share in 2022 and is expected to exhibit the highest CAGR from 2022 to 2030.
Architecture-Based Insights
The CT scanner market is categorized by architecture into C-arm CT Scanners and O-arm CT Scanners, with the C-arm CT Scanners segment leading the market in 2022.
Technology-Based Insights
The CT scanner market is segmented by technology into high slice CT, midsize CT, low slice CT, and cone beam CT, with the high slice CT segment holding the largest market share in 2022.
Application-Based Insights
The CT scanner market is segmented by application into oncology, neurology, orthopedics, and other applications, with the neurology applications segment holding the largest market share in 2022.
End User-Based Insights
The CT scanner market is categorized by end users into hospitals, diagnostic centers, research laboratories, and veterinary clinics. The hospital segment held the largest market share in 2022 and is projected to register the highest CAGR from 2022 to 2030.
CT Scanner Market Report Scope Regional Analysis
North America is anticipated to achieve the highest CAGR in the global CT scanner market from 2022 to 2030. North America held the largest market share in 2022 and is expected to maintain its leading position throughout the forecast period. The North American market is segmented into the US, Canada, and Mexico, with the US holding the largest share due to the rising prevalence of inflammatory diseases, the presence of major industry players, advancements in the healthcare sector, the introduction of innovative CT scan systems, and technological progress in CT scans in the region.
Key players in the global CT scanner market include GE Healthcare, Siemens Healthcare Private Limited, Koninklijke Philips N.V., TOSHIBA IT and CONTROL SYSTEMS CORPORATION, HTSI Healthcare Solutions, Shimadzu Corporation, SAMSUNGHEALTHCARE.COM, Neusoft Corporation, Medtronic, and Shenzhen Anke High-Tech Co., Ltd. These leading companies are focused on expanding and diversifying their market presence and clientele, which is expected to positively impact the CT scanner market.
Some notable developments by major market players include:
In November 2022, FUJIFILM launched the SCENARIA View Focus Edition, a premium CT scanner in the US, featuring Cardio StillShot, an advanced Cardiac Motion Correction technology that provides 6x higher temporal resolution than traditional image reconstruction methods. This device is suitable for both routine and advanced clinical applications and was introduced at RSNA 2022.
In April 2022, Wipro GE Healthcare launched its advanced Revolution Aspire CT scanner, designed and manufactured entirely in India at the Wipro GE Medical Devices Manufacturing plant, offering enhanced imaging intelligence for more accurate clinical diagnoses.In November 2021, Siemens Healthineers launched Naeotom Alpha, the first photon-counting CT scanner approved for clinical use in the USA and Europe, which offers significant improvements, including enhanced resolution and a reduction in radiation dose by up to 45% for ultra-high-resolution scans compared to conventional CT detectors.